Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors
Authors
Keywords
Pazopanib, Lapatinib, Testicular cancer, Germ-cell tumors, Cisplatin, Refractory
Journal
BMC CANCER
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-08-11
DOI
10.1186/1471-2407-13-382
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor
- (2013) M. Juliachs et al. INTERNATIONAL JOURNAL OF CANCER
- A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
- (2012) Massimo Cristofanilli et al. BREAST CANCER RESEARCH AND TREATMENT
- Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
- (2012) B Nitzsche et al. BRITISH JOURNAL OF CANCER
- SKLB1206, a Novel Orally Available Multikinase Inhibitor Targeting EGFR Activating and T790M Mutants, ErbB2, ErbB4, and VEGFR2, Displays Potent Antitumor Activity Both In Vitro and In Vivo
- (2012) Y. Pan et al. MOLECULAR CANCER THERAPEUTICS
- Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
- (2012) D. P. Kodack et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
- (2011) K. Oechsle et al. ANNALS OF ONCOLOGY
- Multitargeted receptor tyrosine kinase inhibition: An antiangiogenic strategy in non-small cell lung cancer
- (2011) Mark A. Socinski CANCER TREATMENT REVIEWS
- Pazopanib for the treatment of renal cancer
- (2011) Brian Rini et al. EXPERT OPINION ON PHARMACOTHERAPY
- Overview of anti-angiogenic agents in development for ovarian cancer
- (2011) Robert A. Burger GYNECOLOGIC ONCOLOGY
- Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update
- (2011) D. Koychev et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours
- (2010) B Nitzsche et al. BRITISH JOURNAL OF CANCER
- Pazopanib: Clinical development of a potent anti-angiogenic drug
- (2010) Fabio A.B. Schutz et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy Compared With Pazopanib Plus Lapatinib Combination Therapy in Patients With Advanced and Recurrent Cervical Cancer
- (2010) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
- (2010) Keith C Bible et al. LANCET ONCOLOGY
- Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
- (2009) R Kumar et al. BRITISH JOURNAL OF CANCER
- Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance
- (2009) G. N. Naumov et al. CLINICAL CANCER RESEARCH
- Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors
- (2009) W. Castillo-Avila et al. CLINICAL CANCER RESEARCH
- Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
- (2009) Darren R. Feldman et al. INVESTIGATIONAL NEW DRUGS
- Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
- (2009) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib
- (2009) Ronald M. Bukowski et al. NATURE REVIEWS DRUG DISCOVERY
- Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines
- (2009) K A Olaussen et al. ONCOGENE
- Late relapse of germ cell tumors
- (2009) Jan Oldenburg et al. WORLD JOURNAL OF UROLOGY
- European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II
- (2008) Susanne Krege et al. EUROPEAN UROLOGY
- Targeted therapies for patients with germ cell tumors
- (2008) Martin H Fenner et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Medical Treatment of Advanced Testicular Cancer
- (2008) Darren R. Feldman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor†
- (2008) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started